Price T Rowe Associates Inc Lantheus Holdings, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,255,648 shares of LNTH stock, worth $112 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,255,648
Previous 1,240,603 1.21%
Holding current value
$112 Million
Previous $99.6 Million 38.35%
% of portfolio
0.02%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$77.7 - $123.62 $1.17 Million - $1.86 Million
15,045 Added 1.21%
1,255,648 $138 Million
Q2 2024

Aug 14, 2024
SELL
$58.87 - $83.05 $8.75 Million - $12.3 Million
-148,623 Reduced 10.7%
1,240,603 $99.6 Million
Q1 2024

May 15, 2024
SELL
$51.07 - $68.26 $12.5 Million - $16.7 Million
-244,643 Reduced 14.97%
1,389,226 $86.5 Million
Q4 2023

Feb 14, 2024
BUY
$55.6 - $77.89 $7.04 Million - $9.86 Million
126,638 Added 8.4%
1,633,869 $101 Million
Q3 2023

Nov 14, 2023
SELL
$60.27 - $90.75 $1.18 Million - $1.77 Million
-19,555 Reduced 1.28%
1,507,231 $105 Million
Q2 2023

Aug 14, 2023
BUY
$82.41 - $99.65 $19.4 Million - $23.5 Million
235,326 Added 18.22%
1,526,786 $128 Million
Q1 2023

May 15, 2023
BUY
$47.76 - $82.86 $12 Million - $20.9 Million
251,963 Added 24.24%
1,291,460 $107 Million
Q4 2022

Feb 14, 2023
SELL
$48.76 - $77.67 $10.5 Million - $16.8 Million
-216,174 Reduced 17.22%
1,039,497 $53 Million
Q3 2022

Nov 14, 2022
SELL
$61.42 - $86.29 $65.2 Million - $91.6 Million
-1,061,220 Reduced 45.8%
1,255,671 $88.3 Million
Q2 2022

Aug 15, 2022
SELL
$55.54 - $72.65 $14.9 Million - $19.5 Million
-268,335 Reduced 10.38%
2,316,891 $153 Million
Q1 2022

May 16, 2022
BUY
$24.28 - $56.64 $10.2 Million - $23.8 Million
419,855 Added 19.39%
2,585,226 $143 Million
Q4 2021

Feb 14, 2022
SELL
$22.54 - $30.44 $2.58 Million - $3.49 Million
-114,540 Reduced 5.02%
2,165,371 $62.6 Million
Q3 2021

Nov 15, 2021
SELL
$24.23 - $28.59 $13.3 Million - $15.7 Million
-549,403 Reduced 19.42%
2,279,911 $58.5 Million
Q2 2021

Aug 16, 2021
SELL
$19.51 - $27.64 $1.39 Million - $1.97 Million
-71,322 Reduced 2.46%
2,829,314 $78.2 Million
Q1 2021

May 17, 2021
SELL
$13.77 - $21.66 $11.9 Million - $18.8 Million
-867,437 Reduced 23.02%
2,900,636 $62 Million
Q4 2020

Feb 16, 2021
BUY
$10.75 - $14.91 $40.5 Million - $56.2 Million
3,768,073 New
3,768,073 $50.8 Million

Others Institutions Holding LNTH

# of Institutions
541
Shares Held
68.3M
Call Options Held
679K
Put Options Held
423K
View Full List

About Lantheus Holdings, Inc.

LNTH Quotes by TradingView
  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.16B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email